Pharmaceutical Market Access and Drug Safety Act of 2005

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeiting Drug Prevention Act, pharmaceutical counterfeiting HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

Client expense: $6,000,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical countefeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology HR 4642, Wired for Health Act, health information technology S 1418, Wired for Health Act, health information technology S 2300, Lower Priced Drug Act, generic drug access HR 5005, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

Client expense: $6,000,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importaion, patent issues

Client expense: $6,000,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

Client expense: $5,800,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

Client expense: $5,800,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

Client expense: $5,800,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Agriculture/food-related provisions of: H.R.328, to amend the Federal Food, Drug and Cosmetic Act. H.R.653, to amend title II of the Social Security Act. H.R.700, to amend the Federal Food, Drug and Cosmetic Act. H.R.750, to amend the Social Security Act and the Internal Revenue Code of 1986. H.R.880, to amend Part C of title XVIII of Social Security Act regarding rural health care. H.R.1626, to amend part C of title XVII of the Social Security Act. H.R.1776, to reform Social Security. H.R.1819, to amend title XVIII of the Social Security Act. H.R.2014, to amend title XVIII of the Social Security Act regarding rural health care. H.R.2073, to amend the Internal Revenue Code of 1986. H.R.2350, to amend title XVIII of the Social Security Act regarding rural health care. H.R.2525, to amend title XVIII of the Social Security Act regarding rural health care. H.R.2562, to reauthorize the Office of National Drub Control Policy Act. S.292, to establish a procedure to safeguard the Social Security Trust Funds. S.334, to amend the Federal Food, Drug and Cosmetic Act. S.933, to amend title XVIII of the Social Security Act regarding rural health care. S.1108, to amend title XVIII of the Social Security Act regarding rural health care. S.1109, to amend title XVIII of the Social Security Act regarding rural health care. S.1952, to provide grants for rural health information technology development. Issues other than legislation: Expansion of health care access and opportunities in rural areas. Funding for rural health care facilities. Patients “Bill of Rights” proposals. Social Security.

Client expense: $511,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Indian Affairs (BIA), Commodity Futures Trading Commission (CFTC), Council of Economic Advisers (CEA), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Maritime Administration (MARAD), Natl Aeronautics & Space Administration (NASA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

e) S. 109, "Pharmaceutical Market Access Act of 2005". f) S. 334, "Pharmaceutical Market Access & Drug Safety Act of 2005". g) Issues related to clinical trial data bank. h) S. 470, H.R. 3196, "Fair Access to Clinical Trials Act". i) H.R. 6257, "Access to Life-Saving Medicines Act". a) Issues related to Drug Safety, Generic Biologics & Drug Approvals, FDA User Fees. b) S.930, "Food & Drug Administration Act of 2005". c) H.R. 2090, "Food & Drug Administration Improvement Act of 2005". d) H.R. 700, "Pharmaceutical Market Access & Drug Safety Act of 2005" - Importation.

Client expense: $1,231,846 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 700/S.334 - Pharmaceutical Market Access & Drug Safety Act of 2005 Legislation on issues pertaining to proposed Medical Prescription drug benefits Legislation on issues regarding FDA regulation of prescription drugs Congressional oversight on drug safety S. 109/H.R. 328 - Pharmaceutical Market Access Act of 2005

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 471, Stem Cell Research Enhancement Act of 2005. Biologics, generics, importation issues. FDA issues. Drug safety issues. Clinical trial issues. Conflict of interest, follow on biologics, steroid abuse, stem cells. PDUFA. HR 2090, Food and Drug Administration Improvement Act of 2005. S 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing issues. HR 328, Pharmaceutical Market Access Act of 2005. HR 6143, Ryan White HIV/AIDS Treatment Modernization Act of 2006. S 3807, Bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. S 4016 & HR 6257, Bill to amend the Public Health Service Act to provide for the licensing of comparable biological products, and for other purposes HR 2565, Office of National Drug Control Reauthorization Act. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005. HR 810, Stem Cell Research Enhancement Act of 2005. S 109, Pharmaceutical Market Access Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

FDA, drug approval, generics biologics, importation, clinical trial, drug and safety, PDUFA, conflict of interest HR 2090, Food and Drug Administration Improvement Act of 2005 HR 6257, Access to Life-Saving Medicine Act S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 4016, Access to Life-Saving Medicine Act H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, Importation S.109/H.R.328, Pharmaceutical Market Access Act of 2005 S.334, Pharmaceutical Market and Drug Safety Act of 2005 S.930, Food and Drug Administration Safety Act of 2005

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Drug safety clinical trials importation issues; conflict of interest. PDUFA S 3802, To amend the Consolidated Omnibus Budget Reconciliation Act of 1985 to expand the county organized health insuring organizations authorized to enroll Medicaid beneficiaries. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005 S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 328, Pharmaceutical Market Access Act of 2005. S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005

Client expense: Not reported · Firm income: $60,000

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC)

Bioshield reauthorization. S 1873 - Biodefense and Pandemic Vaccine and Drug Development Act of 2005. S 1437 - Bioterror and Pandemic Preparedness Protection Act. HR 5533 - Biodefense and Pandemic Vaccine and Drug Development Act of 2006. S 3807, Enhancing Drug Safety and Innovation Act of 2006. HR 6257, Access to Life-Saving Medicine Act. S 4016, Access to Life-Saving Medicine Act. HR 6143, Ryan White HIV/AIDS Treatment Modernization Act of 2006 Drug Safety, Clinical Trials, drug importation. HR 700/S 334 - Pharmaceutical Market Access and Drug Safety Act of 2005. S 109/HR 328 - Pharmaceutical Market Access Act of 2005. S 930 - Food and Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

e) S. 109, "Pharmaceutical Market Access Act of 2005". f) S. 334, "Pharmaceutical Market Access & Drug Safety Act of 2005". g) Issues related to clinical trial data bank. h) S. 470, H.R. 3196, "Fair Access to Clinical Trials Act". i) H.R. 6257, "Access to Life-Saving Medicines Act". a) Issues related to Drug Safety, Generic Biologics & Drug Approvals, FDA User Fees. b) S.930, "Food & Drug Administration Act of 2005". c) H.R. 2090, "Food & Drug Administration Improvement Act of 2005". d) H.R. 700, "Pharmaceutical Market Access & Drug Safety Act of 2005" - Importation.

Client expense: $1,231,846 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

S.109, Pharmaceutical Market Access Act of 2005, S.184, Safe IMPORT Act of 2005, Safe Importation of Medical Products and Other Rx Therapies Act of 2005, S.334, Pharmaceutical Market Access and Drug Safety Act of 2005, General discussion regarding drug reimportation, pharmaceutical distribution issues, recent issues with importation and adulterated drugs, ordering and dispensing technology related to hospital pharmacy and out-patient pharmacy activities, drug pricing, prescription drug discount cards, internet drug sales, S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005, H.R.2345, Counterfeit Drug Enforcement Act of 2005, H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, FY2005 Appropriations Act for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, S.2668, Reducing Fraudulent and Imitation Drugs Act of 2006, S.2582, Preserve Access to Affordable Generics Act, H.R.5156, Counterfeit Drug Prevention Act of 2006, S.2315, Methamphetamine Awareness and Prevention Act of 2006, H.R.4763, Methamphetamine Education Act, H.R.4829, Reducing Fraudulent and Imitation Drugs Act of 2006 H.R.314, Combat Meth Act of 2005, H.R.328, Pharmaceutical Market Access Act of 2005, S.103, Combat Meth Act of 2005,

Client expense: $320,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

Client expense: $7,720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

Client expense: $7,720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

Client expense: $7,720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Direct to Consumer Advertising issues. S.334-Pharmaceutical Market Access & Drug Safety Act of 2005 - re drug importation. S.3807-Enhancing Drug Safety & Innovation of 2006. H.R.5441-Homeland Security Appropriations Bill-re importation issues.

Client expense: $1,380,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3588, Medicare Home Health Telehealth Access Act of 2005. H.R.5647 / S.3708, FY07 Labor, HHS, Education Appropriations, for provisions relating to health technology funding. H.R.4157, Health Information Technology Promotion Act of 2005. S.334, Pharmaceutical Market Access and Drug Safety Act of 2005. H.R. 6063, Remote Monitoring Access Act of 2006.

Client expense: $2,380,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Railroad Administration, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Aeronautics & Space Administration (NASA), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Coast Guard (USCG), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

Legislation regarding pandemic vaccine production: H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; S.1437, Bioterror Pandemic Preparedness Protection Act;S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005. Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Legislation controlling access to precursor chemicals for meth production and/or combating meth: H.R.1056, Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.152, Preserving Access to Affordable Drugs Act of 2005; H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act Reauthorization; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.3324, Arrest Methamphetamine Act of 2005; H.R.3889, The Methamphetamine Elimination Act; H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.798, Methamphetamine Remediation Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.103, Combat Meth Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.1361, A bill to amend the Controlled Substances Act to treat drug offenses involving crystal meth similarly to drug offenses involving crack cocaine; S.1437, Bioterror Pandemic Preparedness Protection Act; S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, H.CON.RES.75, Expressing the sense of the congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to the United States consumers, and for other purposes; H.R.1056,

Client expense: $820,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2345 Counterfeit Drug Enforcement Act of 2005 H.R. 4829 Reducing Fruadulant and Imitation Drug Act of 2005: S. 2300 Lower PRICED Drug Act. Meetings with Members of Congress regarding generic biologics and Food and Drug Administration regulatory activity of interest to the Registrant. Various bills regarding the importation of prescription drugs including: H.R. 328, S. 109, H.R. 700, S. 334. H.R. 753, and S. 184. H.R. 5993, S. 3695: legislation to prohibit the marketing of authorized generic drugs.

Client expense: $440,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1652 Access to Legal Pharmaceuticals Act H.R. 1808 Safe Online Drug Act of 2005 H.R. 1815 National Defense Authorization Act for Fiscal Year 2006 – Pharmacy Program H.R. 4769 Prescription Drug Abuse Elimination Act of 2006 H.R. 5122 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program H.R. 5280 Dextromethorphan Distribution Act of 2006 H.R. 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 – Prescription Drug Importation H.R. 5441 Department of Homeland Security Appropriations Act, 2007 – Prescription Drug Importation S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 778 Pharmacy Consumer Protection Act of 2005 S. 809 Access to Legal Pharmaceuticals Act S. 2766 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program S. 3807 Enhancing Drug Safety and Innovation Act of 2006 S. 3546 Dietary Supplement and Nonprescription Drug Consumer Protection Act Pharmacy Compounding Counterfeit Drugs Health Information Technology Implementation of the Combat Methamphetamine Epidemic Act of 2005 FDA Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act (PDMA) FDA Docket No. 2006N-0283 re: the proposed survey of physicians’ perceptions on the impact of early risk communication about medical products DEA Docket No. DEA-2911 re: retail sales of scheduled listed chemical products and self-certification of regulated sellers of scheduled listed chemical products CMS-1321-P re: proposed revisions to the payment policies under the physician fee schedule for calendar year 2007 DEA-287N re the issuing of multiple prescriptions for Schedule II Controlled Substances FDA Re: Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act Proposed revisions to the United States Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. H.R. 1539 A bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions, and for other purposes.

Client expense: $299,853 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Competitive Bidding for DME Implementation of DRA In-Vitro Diagnostics Legislation Medicare Competitive Acquistion Program (CAP) Medicare Competitive Bidding for Durable Medical Equipment Medicare Fraud and Abuse Medicare Part B Drug Payment Reform Medicare Part D Implementation Medicare Payment Policy Medicare Hospital Outpatient Rule Medicare Pay for Performance - Inpatient Prospective Payment System - Proposed Rule Medicare Coverage of I-BOT Medicaid Reform Mental Health Limitation for Scientific Products Pain Management Legislation Physician Fee Schedule Rule Out Patient Physician System Self-Administration Rule HR 328, HR 376, S 334, S 813 - Medicare Prescription Drug Coverage and Pricing Information HR 4157 - HIT/ICD-10 Coding HR 5179 - Amend Title XVIII of Social Security Act HR 5369 - Advanced Laboratory Diagnostics Act of 2006 HR 5465, S 340 Community Cancer Care Preservation Act of 2006 HR 6063- Remote Monitoring Legislation S 239, S 445 - Medicare Prescription Druge Coverage and Pricing Non-Interference AIDS Drugs Assistance Program Appropriations Chronic Care Improvement Program (CCIP) Clinical Lab Fee Schedule Reimbursement Rates Competitive Bidding for Laboratory Services

Client expense: $2,080,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office

S 3807, Enhancing Drug Safety and Innovation Act of 2006 HR 6257, Access to Life-Saving Medicine Act Drug Approval Issues, Drug Safety Issues, FDA Issues Clinical Trials Conflict of Interest, Follow-on Biologics, PDUFA IV Issues relating to generics, biotechnology, and drug reimportation H.R.700/S334 Pharmaceutical Market Access and Drug and Safety Act of 2005/S334 H.R.328/S109 Pharmaceutical Market Access Act of 2005 S930 Food and Drug Administration Safety Act of 2005

Client expense: Not reported · Firm income: $100,000

Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.109, Pharmaceutical Market Access Act of 2005, S.184, Safe IMPORT Act of 2005, Safe Importation of Medical Products and Other Rx Therapies Act of 2005, S.334, Pharmaceutical Market Access and Drug Safety Act of 2005, General discussion regarding drug reimportation, pharmaceutical distribution issues, recent issues with importation and adulterated drugs, ordering and dispensing technology related to hospital pharmacy and out-patient pharmacy activities, drug pricing, prescription drug discount cards, internet drug sales, S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005, H.R.2345, Counterfeit Drug Enforcement Act of 2005, H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, FY2005 Appropriations Act for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, S.2668, Reducing Fraudulent and Imitation Drugs Act of 2006, S.2582, Preserve Access to Affordable Generics Act, H.R.5156, Counterfeit Drug Prevention Act of 2006, S.2315, Methamphetamine Awareness and Prevention Act of 2006, H.R.4763, Methamphetamine Education Act, H.R.4829, Reducing Fraudulent and Imitation Drugs Act of 2006 H.R.314, Combat Meth Act of 2005, H.R.328, Pharmaceutical Market Access Act of 2005, S.103, Combat Meth Act of 2005,

Client expense: Not reported · Firm income: $40,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 5 - Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2005; H.R. 4544 - 340B Program Revision and Expansion Act of 2005; S. 1840/H.R. 3547 Safety Net Inpatient Drug Affordability Act of 2005; S.4/S. 1503 - Healthy America Act of 2005; S. 1420/H.R. 3423 - Medical Device User Fee Stabilization Act of 2005; H.R. 2234 - 21st Century Health Information Act of 2005; S. 3685/H.R. 5993 - To amend the Federal Food, Drug and Comestic Act to prohinit the marketing of authorized generic drug; S. 1903 - Generic Presription Drug Fairness Act of 2005; S. 3582 - Preserve Access to Affordable Generic Act of 2006; S. 4016/H.R. 6257 - Access to Life-Saving Medicine Act of 2006; S. 306/H.R. 1227 - Genetic Information Non-Discrimination act of 2005 S. 334/S. 109 - Pharmacetuical Market Access and Drug Safety Act of 2005; S. 1418 - Wired for Health Care Quality Act of 2005; S. 1233 - Information Technology for Health Care Quality Act of 2005

Client expense: $1,040,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

H.R. 4127, Data Accountabilty and Trust Act; H.R. 3997, Financial Data Protection Act; H.R. 3374, Consumer Notification and Financial Data Protection Act; H.R. 3375, Financial Data Security Act; S. 1408, Identity Theft Protection Act; S. 3568, the Data Security Act of 2006; H.R. 5318, the Cyber-Security Enhancement and Consumer Data Protection Act. Implementation of the FACT Act. Issues related to the use of payment cards in connection with purchase of prescription medications over the Internet including provisions in: S. 184, Safe IMPORT Act of 2005; and S. 334, Pharmaceutical Market Access and Drug Safety Act of 2005. General issues relating to interchange fees; general issues relating to credit card practices. H.R. 4411, the Unlawful Internet Gambling Enforcement Act and H.R. 4777; the Internet Gambling Prohibition Act, provisions relating to financial services. Issues related to use of payment cards in connection with purchase of illegal material over the Internet. Issues related to reliance on payment card providers in connection with taxpayer compliance with the Internal Revenue Code. All provisions pertaining to data security, customer notification of security breaches, and mitigation of harm resulting from security breaches in the following legislation: S. 1332, Personal Data Privacy and Security Act; S. 768, Comprehensive Identity Theft Prevention Act;

Client expense: Not reported · Firm income: $320,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 328 and S. 109 - Pharmaceutical Market Access Act of 2005 - all provisions relating to re-importation of prescription drugs; H.R. 700 & S. 334 - Pharmaceutical Market Access and Drug Safety Act of 2005 - same as above

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 309 To amend the Internal Revenue Code of 1986 to provide for the disposition of unused health benefits in cafeteria plans and flexible spending arrangements. S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 354 Help Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 or the `HEALTH Act of 2005 S. 406 Small Business Health Fairness Act of 2005 S. 544 Patient Safety and Quality Improvement Act of 2005 S. 577 HIPAA Recreational Injury Technical Correction Act S. 772 Workforce Health Improvement Program Act of 2005 S. 978 Healthcare Tax Relief for the Uninsured Act of 2005 S. 1015 Health Care Choice Act of 2005 S. 1244 Long-Term Care and Retirement Security Act of 2005 S. 1356 Medicare Value Purchasing Act of 2005 S. 1418 Wired for Health Care Quality Act S. 1447 Tax Technical Corrections Act of 2005 S. 1932 Deficit Reduction Act of 2005 S. 3585 HSA Improvement and Expansion Act of 2006 HR 5 Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2005 HR 525 Small Business Health Fairness Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 1227 Genetic Information Nondiscrimination Act of 2005 HR 1402 Paul Wellstone Mental Health Equitable Treatment Act of 2005 HR 1634 Workforce Health Improvement Program Act of 2005 HR 1872 Health Coverage for the Uninsured Act of 2005 HR 1998 To amend the Internal Revenue Code of 1986 to provide for the disposition of unused benefits in health flexible spending arrangements. HR 2234 21st Century Health Information Act of 2005 HR 2355 Health Care Choice Act of 2005 HR 2682 Long-Term Care and Retirement Security Act of 2005 HR 2793 HIPAA Recreational Injury Technical Correction Act HR 2830 Pension Protection Act of 2005 HR 3204 State High Risk Pool Funding Extension Act of 2005 HR 3205 Patient Safety and Quality Improvement Act of 2005 HR 3376 Tax Technical Corrections Act of 2005 HR 4157 Health Information Technology Promotion Act of 2006 HR 4241 Deficit Reduction Act of 2005 HR 4262 Tax-Free Health Savings Act of 2006 HR 4511 Health Flex Act HR 5586 HSA Premium Affordability Act of 2006 HR 5743 HSA Improvement and Expansion Act of 2006 HR 6111 The Tax Relief and Health Care Act of 2006 HR 6134 Health Opportunity and Patient Empowerment Act of 2006 HR 5262 Tax Free Health Savings Act of 2006 S. 4 Healthy America Act of 2005 S. 16 Affordable Health Care Act S. 288 State High Risk Pool Funding Extension Act of 2005 S. 306 Genetic Information Nondiscrimination Act of 2005

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office

Fair Access to Clinical Trials Act (S470/HR3196); FDA Improvement Act (S930/HR2090); Wired for Health Care Quality Act (S1418); Pharmaceutical Market Access and Drug Safety Act (S109/S334/HR328/HR700); Labor-HHS Appropriations; AHRQ Comparative Effectiveness Research (HR 5975); Reauthorization of PDUFA; Health Information Technology (HR 4157/S 1418) FDA reform regarding oversight of drug safety.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Medicare law--P.L. 108-173; all sections related to prescription drugs. S. 184, Safe Importation of Medical Products and Other Rx Therapies Act of 2004. S. 2307, Reliable Entry for Medicines at Everyday Discounts through Importation with Effective Safeguards Act of 2004. S. 4, Medicare Modernization Act Implementation. H.R. 2744, Agriculture Appropriations, relating to FDA appropriations. S. 328, Pharmaceutical Market Access Act. H.R. 2744, Agriculture, Rural Development, Food & Drug Administration and Related Agencies Appropriations Act, 2004, sections related to FDA funding. S. 334/H.R. 700, Pharmaceutical Market Access and Drug Safety Act of 2005, relating to reimportation.

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HEALTH CARE QUALITY H.R.5399 HEALTH CARE QUALITY H.R.5399 HEALTH CARE QUALITY H.R.5399 HEALTH CARE QUALITY S.3678 HEALTH CARE QUALITY S.3678 HEALTH CARE INSURANCE S.1955 HEALTH CARE INSURANCE S.1955 HEALTH CARE INSURANCE S.1955 HEALTH ISSUES HEALTH ISSUES S.2300 HEALTH ISSUES S.334 HEALTH ISSUES S.2300 HEALTH ISSUES S.334 HEALTH ISSUES S.2300 HEALTH ISSUES S.334 HEALTH CARE QUALITY HEALTH CARE QUALITY H.R.5399 HEALTH CARE QUALITY H.R.5399 HEALTH CARE QUALITY H.R.5399

Client expense: $11,040,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Reserve System, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of

PRESCRIPTION DRUGS PRESCRIPTION DRUGS H.R.5847 PRESCRIPTION DRUGS S.334 PRESCRIPTION DRUGS S.334 PRESCRIPTION DRUGS S.334 PRESCRIPTION DRUGS S.3708 PRESCRIPTION DRUGS S.334 PRESCRIPTION DRUGS S.334

Client expense: $11,040,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Reserve System, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of

LONG TERM CARE LONG TERM CARE H.R.2682 LONG TERM CARE H.R.2682 LONG TERM CARE H.R.2682 LONG TERM CARE H.R.3607 LONG TERM CARE S.1227 LONG TERM CARE S.1932 LONG TERM CARE S.1932 LONG TERM CARE S.493 LONG TERM CARE S.1932 LONG TERM CARE S.493 MEDICAID MEDICAID H.R.4993 MEDICAID S.493 MEDICAID S.493 MEDICAID S.493 MEDICARE MEDICARE H.R.5399 MEDICARE H.R.5969 MEDICARE H.R.5399 MEDICARE H.R.5969 MEDICARE H.R.5399 MEDICARE H.R.5699 MEDICARE H.R.5399 MEDICARE H.R.5399 MEDICARE S.334 MEDICARE S.3897 MEDICARE S.334 MEDICARE S.3897 MEDICARE S.334 MEDICARE S.3897

Client expense: $11,040,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Reserve System, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of

Drug safety and importation issues, Clinical trials. Generics Biologics HR 328, Pharmaceuticals Market Access Act of 2005. HR 2090, Food and Drug Administration Improvement Act of 2005. S 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing. S 3807, Enhancing Drug Safety and Innovation Act of 2006. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005. S 109, Pharmaceutical Market Access Act of 2005. S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

1. S. 334, HR 700, S. 1551, S. 109, HR 2744-Specifically, provisions relating to the importation of prescription drugs. 2. S. 930-A bill to amend the Food and Drug Administration Safety Act, with respect to drug safety.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 109- Pharmaceutical Market Access Act of 2005; S. 184-Safe Import Act of 2005; H.R. 700, S. 334-Pharmaceutical Market Access and Drug Safety Act of 2005; and S. 930 Food & Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug importation, drug safety issues, clinical trials Conflict of Interest, PDUFA, Drug pricing S 2766, national Defense Authorization Act for Fiscal Year 2007; drug pricing. HR 2090, Food and Drug Administration Improvement Act of 2005 HR 328, Pharmaceutical Market Access Act of 2005. S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 4016, Access to Life-Saving Medicine Act HR 6257, Access to Life-Saving Medicine Act HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, Importation. S 109, Pharmaceutical Market Access Act of 2005. S 334 Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $180,000

Government targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE

43. H.R. 1539, a bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug 44. S. 338, the Bipartisan Commission on Medicaid Act of 2005 45. H.R. 985, the Bipartisan Commission on Medicaid Act of 2005 46. S. Con.Res.18, Budget FY2006 Appropriations resolution 47. H. Con.Res.95, 18, Budget FY2006 Appropriations resolution 48. S. 1262, the Health Technology to Enhance Quality Act of 2005 49. S.3678, the Pandemic and All-Hazards Preparedness Act 50. S.2564, the Biodefense and Pandemic Vaccine and Drug Development Act of 2006 51. H.R. 5533, the Biodefense and Pandemic Vaccine and Drug Development Act 52. H.R. 5262, Tax Free Savings Act of 2006 53. S. 3546, the Dietary Supplement and Nonprescription Drug Consumer Protection Act 54. H.R. 4157, the Health Information Technology Promotion Act of 2006 55. S. 2766, the National Defense Authorization Act for Fiscal Year 2007 56. H.R.5122, the National Defense Authorization Act for Fiscal Year 2007 57. S.2810, the Medicare Late Enrollment Assistance Act of 2006 58. H.R.5399, the Medicare Drug Benefit Enrollment Fairness Act of 2006 59. H.R. 5182, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 60. S. 2563, the Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 61. S. 2664, the Pharmacy Access Improvement (PhAIm) Act of 2006 62. H.R. 4769, the Prescription Drug Elimination Act of 2006 63. S. 2300, the Lower Prices With Increased Competition and Efficient Development of Drugs Act (the Lower Priced Drugs Act) 64. H.R. 5166 – The Independent Pharmacy Protection Act of 2006 65. S. 2181, the Medicare State Reimbursement Act 66. S. 2183, the Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act 67. H.R. 4297, the Tax Relief Extension Reconciliation Act 68. H.R. 5384, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 69. H.R.5441, the Department of Homeland Security Appropriations Act, 2007 70. S. 2020, Tax Relief Act of 2005 71. HR 5122 - FY2007 National Defense Authorization Act (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 72. HR 5182 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 73. S. 2563 - Pharmacist Access and Recognition in Medicare (PHARM) Act of 2006 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 74. S. 1932 - Deficit Reduction Act (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 1. H.R. 4241, the Deficit Reduction Act of 2005 2. S. 1932, the Senate Deficit Reduction Act of 2005 3. H.R. 6111, the Tax Relief and Health Care Act of 2006 4. H.R. 5280, the Dextromethorphan Distribution Act of 2006 5. S.3807. the Enhancing Drug Safety and Innovation Act of 2006 6. H.R. 6257, the Access to Life-Saving Medicine Act 7. H.R. 5970, the Estate Tax and Extension of Tax Relief Act of 2006 8. S. 1716, Emergency Health Care Relief Act of 2005 9. H.R. 4297, the Tax Relief Extension Reconciliation Act 10. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 11. S. 544, the Patient Safety and Quality Improvement Act of 2005 12. H.R. 3205, the Patient Safety and Quality Improvement Act of 2005 13. H.R. 1132, the National All Schedules Prescription Electronic Reporting Act of 2005 14. S. 518, the National All Schedules Prescription Electronic Reporting Act of 2005 15. S. 1392, the Federal Trade Commission Reauthorization Act of 2005 16. S. 334, the Pharmaceutical Market Access and Drug Safety Act 17. H.R. 700, the Pharmaceutical Market Access and Drug Safety Act of 2005 18. S. 309, the Pharmaceutical Market Access Act 19. H.R. 328, the Pharmaceutical Market Access Act 20. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 21. H.R. 1808, the Safe Online Drug Act of 2005 22. S. 399, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 23. H.R. 840, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 24. S. 14, the Fair Wage, Competition, and Investment Act of 2005 25. S. 534, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 26. H.R. 5, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 27. H.R. 1669, the Pharmacy Benefit Manager Transparency Act of 2005 28. H.R. 1671, the Community Pharmacy Fairness Act of 2005 29. S. 103, the Combat Meth Act of 2005 30. H.R. 314, the Combat Meth Act of 2005 31. S. 102, the Exile Meth Act 32. H.R. 313, the Exile Meth Act 33. H.R. 3889, Meth Epidemic Elimination Act 34. H.R. 1378, the Ephedrine Alkaloids Regulation Act of 2005 35. H.R. 2829, the Office of National Drug Control Policy Reauthorization Act of 2005 36. H.R. 3617, the Medicare Value-Based Purchasing for Physicians' Services Act of 2005 37. S. 1356, the Medicare Value Purchasing Act of 2005 38. S. 1408, the Identity Theft Protection Act 39. S. 1332, the Personal Data Privacy and Security Act of 2005 40. S. 930, the Food and Drug Administration Safety Act of 2005 41. H.R. 1652, the Access to Legal Pharmaceuticals Act 42. S. 809, the Access to Legal Pharmaceuticals Act See addendum

Client expense: $300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, White House Office

HR 753 / S 184, Safe IMPORT Act of 2005, issues impacting employer costs. HR 2355 / S 1015, Health Care Choice Act of 2005, issues impacting employer costs. Issues related to health care cost containment. HR 525 / S 406, Small Business Health Fairness Act of 2005, issues impacting employer costs. HR 700 / S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, issues impacting employer costs. CONTINUED ON NEXT PAGE

Client expense: Not reported · Firm income: $960,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE